Gold and iron oxide nanoparticle-based ethylcellulose nanocapsules for cisplatin drug delivery

Iranian Journal of Pharmaceutical Research

Volumn 10, Issue 3, 2011, Pages 415-424

  Kumar, Kannaiyan Sathish ^a   Jaikumar, Vasudevan ^a  

^a SSN COLLEGE OF ENGINEERING   (India)

Author keywords

Anticancer drug; Coefficient of variation; Drug release; Nanocapsules; Phosphate buffer; Standard deviation

Indexed keywords

CISPLATIN; ETHYL CELLULOSE; GOLD NANOPARTICLE; IRON OXIDE; NANOCAPSULE; NANOPARTICLE; PHOSPHATE BUFFERED SALINE; POLYMER;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CHEMICAL INTERACTION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENVIRONMENTAL TEMPERATURE; EVAPORATION; INFRARED SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84856955663     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Agrahari V, Kabra V and Trivedi P. Development, Optimization and Characterization of Nanoparticle Drug Delivery System of Cisplatin. Proceedings of the 13th International Conference on Biomedical Engineering (ICBME). 2008 Dec 3-6, Singapore.
2. Ghorab MM, Zia H and Luzzi LA. Preparation of controlled release anticancer agent: 5-Fluorouracil-ethycellulose microspheres. J. Microencapsulation (1990).7: 447-454.
3. Pinto Reis C, Neufeld RJ, Ribeiro A and Francisco Veiga. Nanoencapsulation I. methods of preparation of drug loaded polymeric nanoparticles. Nanomedicine (2008) 2: 8-21.
4. Nabuhiro N, Souichiro O, Horacio C and Miyamoto M. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res. (2003) 63: 8977-83.
5. Kikkawa SH, Takagi SH and Tamura H. Preparation of titanate coated magnetite powder for cisplatin delivery. J. Ceramic Society of Japan (2008) 116: 380-383.
6. Yan X and Gemeinhart RA. Cisplatin delivery from poly (acrylic acid-co-methyl methacrylate) microparticles. J. Control. Rel. (2005) 106: 198-208.
7. Ferruti P, Ranucci E, Trotta F, Gianasi E, Evagorou EG, Wasil M, Wilson G and Duncan R. Synthesis, characterisation and antitumour activity of platinum(ii) complexes of novel functionalised poly(amido amine)s. Macromol. Chem. Phys. (1999) 200: 1644-1654.
8. Ferruti P, Marchisio M and Duncan Rsub./sub Poly (amido-amine)s: biomedical applications. Macromol. Rapid Commun. (2002) 23: 332-355.
9. Yellepeddi VK, Kumar A and Palakurthi S. Dendritic Cisplatin as a Nanodevice for Treatment of Ovarian Cancer. Nanotech. Conference and Expo. 2009 May 3-7, Houston, Texas.
10. Avgoustakis K, Beletsi A, Panagi Z, Klepetsanis P, Karydas AG and Ithakissios DS. PLGA-mPEG nanoparticles of cisplatin: in-vitro nanoparticle degradation, in-vitro drug release and in-vivo drug residence in blood properties. J. Controlled Rel. (2002) 79: 123-135.
11. Okassa LN, Marchais H, Douziech-Eyrolles L, Herve K, Cohen-Jonathan S, Munnier E, Souce M, Linassier C, Dubois P and Chourpa I. Optimization of iron oxide nanoparticles encapsulation with PLGA submicron particles. Eur. J. Pharm. Biopharm. (2007) 67: 31-38.
12. Mahboubian A, Hashemein SK, Moghadam S, Atyabi F and Dinarvand R. Preparation and In-vitro Evaluation of Controlled Release PLGA Microparticles Containing Triptoreline. Iranian J. Pharm. Res. (2010) 9: 369-378.
13. Beck LR, Cowsar DR, Lewis DH Cograve RJ, Riddle CT, Lowery SL and Epperly T. A new long acting injectable microcapsule system for the administration of progesterone. Fertility and Sterility (1979) 31: 545-551.